ScholarIQanswers from OpenAlex

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

PaperCitations, authors & open-access status

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee is a paper indexed in ScholarIQ from OpenAlex.

How many citations does PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee have?

ScholarIQcitation count

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee has 347 citations in the OpenAlex counts ScholarIQ stores.

When was PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee published?

ScholarIQyear

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee has 2019 year in the ScholarIQ index.

What is the open-access status of PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee?

ScholarIQoa status

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee has closed oa status in the ScholarIQ index.

What is the DOI of PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee?

ScholarIQdoi

The DOI for PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee is on the source record.

What is the PMID of PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee?

ScholarIQpmid

The PMID for PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee is on the source record.

What is the OpenAlex record for PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee?

ScholarIQopenalex

The OpenAlex for PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial